JP2011508791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011508791A5 JP2011508791A5 JP2010542440A JP2010542440A JP2011508791A5 JP 2011508791 A5 JP2011508791 A5 JP 2011508791A5 JP 2010542440 A JP2010542440 A JP 2010542440A JP 2010542440 A JP2010542440 A JP 2010542440A JP 2011508791 A5 JP2011508791 A5 JP 2011508791A5
- Authority
- JP
- Japan
- Prior art keywords
- lactide
- drug depot
- implantable drug
- fluocinolone
- biodegradable polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 20
- 229940079593 drugs Drugs 0.000 claims 20
- 229920002988 biodegradable polymer Polymers 0.000 claims 9
- 239000004621 biodegradable polymer Substances 0.000 claims 9
- UUOUOERPONYGOS-CLCRDYEYSA-N Fluocinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3C[C@H](F)C2=C1 UUOUOERPONYGOS-CLCRDYEYSA-N 0.000 claims 8
- 229940043075 fluocinolone Drugs 0.000 claims 8
- 206010061218 Inflammation Diseases 0.000 claims 7
- 208000002193 Pain Diseases 0.000 claims 7
- JJTUDXZGHPGLLC-UHFFFAOYSA-N dilactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims 7
- 230000004054 inflammatory process Effects 0.000 claims 7
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 239000011780 sodium chloride Substances 0.000 claims 7
- 229920000954 Polyglycolide Polymers 0.000 claims 6
- 206010052779 Transplant rejections Diseases 0.000 claims 6
- 229920000747 poly(lactic acid) polymer Polymers 0.000 claims 6
- 210000001519 tissues Anatomy 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 229960001347 Fluocinolone Acetonide Drugs 0.000 claims 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N Fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 claims 2
- 229920001710 Polyorthoester Polymers 0.000 claims 1
- 208000008765 Sciatica Diseases 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 239000002745 poly(ortho ester) Substances 0.000 claims 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims 1
Claims (15)
- 疼痛、炎症および/または組織移植片拒絶反応の処置を必要としている患者の疼痛、炎症および/または組織移植片拒絶反応を減少させる、予防するまたは処置するための埋込可能ドラッグデポーであって、ドラッグデポーの約0.5wt.%〜約25wt.%の量のフルオシノロンまたはその薬学的に許容しうる塩と、少なくとも一つの生物分解性ポリマーを含み、ここにおいて、該ドラッグデポーが、フルオシノロンまたはその薬学的に許容しうる塩を、少なくとも3日間にわたって放出することができる、前記埋込可能ドラッグデポー。
- 前記疼痛および/または炎症が、坐骨神経痛による、請求項1に記載の埋込可能ドラッグデポー。
- 前記フルオシノロンまたはその薬学的に許容しうる塩が、ドラッグデポーの約1wt.%〜約20wt.%を構成する、請求項1または2に記載の埋込可能ドラッグデポー。
- 前記少なくとも一つの生物分解性ポリマーが、ドラッグデポーの少なくとも90wt.%を構成する、請求項1ないし3のいずれか1項に記載の埋込可能ドラッグデポー。
- 少なくとも一つの生物分解性ポリマーが、ポリ(ラクチド−コ−グリコリド)(PLGA)、ポリラクチド(PLA)、ポリグリコリド(PGA)、D−ラクチド、D,L−ラクチド、L−ラクチド、D,L−ラクチド−ε−カプロラクトン、D,L−ラクチド−グリコリド−ε−カプロラクトン、ポリ(グリコリド−ε−カプロラクトン)またはその組合せの一つまたはそれを超えるものを含む、請求項1ないし4のいずれか1項に記載の埋込可能ドラッグデポー。
- 少なくとも一つの生物分解性ポリマーが、ポリ(乳酸−コ−グリコール酸)を含み、該ポリ(乳酸−コ−グリコール酸)が、ポリグリコリドおよびポリラクチドの混合物を含む、請求項5に記載の埋込可能ドラッグデポー。
- 前記混合物が、ポリグリコリドより多いポリラクチドを含む、請求項5に記載の埋込可能ドラッグデポー。
- 前記フルオシノロンが、フルオシノロンアセトニドを含む、請求項1ないし7のいずれか1項に記載の埋込可能ドラッグデポー。
- ドラッグデポーが、(i)ボーラス用量のフルオシノロンまたはその薬学的に許容しうる塩を皮膚下部位に放出し;そして(ii)有効量のフルオシノロンまたはその薬学的に許容しうる塩を少なくとも50日間にわたって放出する、請求項1ないし8のいずれか1項に記載の埋込可能ドラッグデポー。
- 少なくとも一つの生物分解性ポリマーが、ポリ(乳酸−コ−グリコール酸)またはポリ(オルトエステル)またはその組合せを含み、そして該少なくとも一つの生物分解性ポリマーが、前記ドラッグデポーの少なくとも80wt.%を構成する、請求項1ないし3のいずれか1項に記載の埋込可能ドラッグデポー。
- 炎症、疼痛および/または組織移植片拒絶反応の処置を必要としている患者の炎症、疼痛および/または組織移植片拒絶反応を減少させる、予防するまたは処置するための埋込可能ドラッグデポーであって、ドラッグデポーの約0.5wt.%〜約25wt.%の量のフルオシノロンアセトニドと、少なくとも一つのポリマーを含み、ここにおいて、該少なくとも一つのポリマーが、ポリ(ラクチド−コ−グリコリド)、D−ラクチド、D,L−ラクチド、L−ラクチド、D,L−ラクチド−カプロラクトンまたはD,L−ラクチド−グリコリド−ε−カプロラクトンの一つまたはそれを超えるものを含む、前記埋込可能ドラッグデポー。
- 炎症、疼痛および/または組織移植片拒絶反応の処置を必要としている患者の炎症、疼痛および/または組織移植片拒絶反応を減少させる、予防するまたは処置するための埋込可能ドラッグデポーであって、該ドラッグデポーが、ドラッグデポーの約0.05wt.%〜約25wt.%の量のフルオシノロンまたはその薬学的に許容しうる塩と、少なくとも一つの生物分解性ポリマーを含む、前記埋込可能ドラッグデポー。
- 前記フルオシノロンまたはその薬学的に許容しうる塩が、ドラッグデポーの約1wt.%〜約15wt.%を構成する、請求項12に記載の埋込可能ドラッグデポー。
- 前記生物分解性ポリマーが、ドラッグデポーの少なくとも80wt.%を構成する、請求項12または13に記載の埋込可能ドラッグデポー。
- 少なくとも一つの生物分解性ポリマーが、ポリ(ラクチドコグリコリド)(PLGA)、ポリラクチド(PLA)、ポリグリコリド(PGA)、D−ラクチド、D,L−ラクチド、L−ラクチド、D,L−ラクチド−カプロラクトン、D,L−ラクチド−グリコリド−カプロラクトンまたはその組合せの一つまたはそれを超えるものを含む、請求項12ないし14のいずれか1項に記載の埋込可能ドラッグデポー。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4621808P | 2008-04-18 | 2008-04-18 | |
US12/413,197 US9125917B2 (en) | 2008-04-18 | 2009-03-27 | Fluocinolone formulations in a biodegradable polymer carrier |
PCT/US2009/041043 WO2009129511A2 (en) | 2008-04-18 | 2009-04-17 | Fluocinolone formulations in a biodegradable polymer carrier |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011508791A JP2011508791A (ja) | 2011-03-17 |
JP2011508791A5 true JP2011508791A5 (ja) | 2011-05-12 |
Family
ID=41199779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010542440A Pending JP2011508791A (ja) | 2008-04-18 | 2009-04-17 | 生物分解性ポリマー担体中のフルオシノロン製剤 |
Country Status (5)
Country | Link |
---|---|
US (2) | US9125917B2 (ja) |
EP (1) | EP2280712A4 (ja) |
JP (1) | JP2011508791A (ja) |
CN (1) | CN101959520A (ja) |
WO (1) | WO2009129511A2 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090110637A1 (en) * | 2007-10-26 | 2009-04-30 | Warsaw Orthopedic, Inc. | LMP and Regulation of Tissue Growth |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US20100239632A1 (en) | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
US20110027331A1 (en) * | 2009-07-29 | 2011-02-03 | Warsaw Orthopedic, Inc. | An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation |
GB201505527D0 (en) | 2015-03-31 | 2015-05-13 | Jmedtech Pte Ltd | Composition |
CA3078555A1 (en) | 2017-10-06 | 2019-04-11 | Foundry Therapeutics, Inc. | Implantable depots for the controlled release of therapeutic agents |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4624255A (en) | 1982-02-18 | 1986-11-25 | Schenck Robert R | Apparatus for anastomosing living vessels |
US4863457A (en) | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
US5922340A (en) | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
US5868789A (en) | 1997-02-03 | 1999-02-09 | Huebner; Randall J. | Removable suture anchor apparatus |
US5522844A (en) | 1993-06-22 | 1996-06-04 | Johnson; Lanny L. | Suture anchor, suture anchor installation device and method for attaching a suture to a bone |
DE69603577T2 (de) * | 1995-02-10 | 1999-11-25 | Medtronic Inc | Verfahren und vorrichtung zur verabreichung von analgetika |
US6046187A (en) | 1996-09-16 | 2000-04-04 | Children's Medical Center Corporation | Formulations and methods for providing prolonged local anesthesia |
ATE203157T1 (de) | 1996-12-20 | 2001-08-15 | Alza Corp | Injizierbare depotgelzubereitung und herstellungsverfahren |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
EP1009390A4 (en) | 1997-07-02 | 2004-05-06 | Euro Celtique Sa | LONG-EFFECT ANESTHESIA INJECTED IN JOINT AND BODY SPACES |
TW577758B (en) | 1997-10-27 | 2004-03-01 | Ssp Co Ltd | Intra-articular preparation for the treatment of arthropathy |
US6069129A (en) | 1998-03-13 | 2000-05-30 | Mrs, Llc | Elastin derived composition and method of using same |
CA2321004C (en) | 1998-05-12 | 2004-05-04 | Scimed Life Systems, Inc. | Manual bone anchor placement devices |
US6632457B1 (en) | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
US6179862B1 (en) | 1998-08-14 | 2001-01-30 | Incept Llc | Methods and apparatus for in situ formation of hydrogels |
US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
US6565874B1 (en) | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
US6143314A (en) | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
US6436099B1 (en) | 1999-04-23 | 2002-08-20 | Sdgi Holdings, Inc. | Adjustable spinal tether |
US6287588B1 (en) | 1999-04-29 | 2001-09-11 | Macromed, Inc. | Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof |
US7094258B2 (en) | 1999-08-18 | 2006-08-22 | Intrinsic Therapeutics, Inc. | Methods of reinforcing an annulus fibrosis |
US7951201B2 (en) | 1999-10-20 | 2011-05-31 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US6461631B1 (en) | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
EP1244388B1 (en) | 1999-12-06 | 2007-01-17 | Warsaw Orthopedic, Inc. | Intervertebral disc treatment device |
US6899716B2 (en) | 2000-02-16 | 2005-05-31 | Trans1, Inc. | Method and apparatus for spinal augmentation |
US6589549B2 (en) | 2000-04-27 | 2003-07-08 | Macromed, Incorporated | Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
WO2002053128A2 (en) | 2001-01-03 | 2002-07-11 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with multiple agents |
US20030152637A1 (en) | 2001-01-25 | 2003-08-14 | Mark Chasin | Local anesthetic, and method of use |
US7229441B2 (en) | 2001-02-28 | 2007-06-12 | Warsaw Orthopedic, Inc. | Flexible systems for spinal stabilization and fixation |
US8617048B2 (en) | 2001-03-09 | 2013-12-31 | Boston Scientific Scimed, Inc. | System for implanting an implant and method thereof |
MXPA01011542A (es) | 2001-11-13 | 2003-05-22 | Alcon Inc | Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel. |
US6974462B2 (en) | 2001-12-19 | 2005-12-13 | Boston Scientific Scimed, Inc. | Surgical anchor implantation device |
KR101101261B1 (ko) | 2002-07-19 | 2012-01-04 | 인스티튜트 오브 머티어리얼스 리서치 & 엔지니어링 | 생체분해성 삼블럭 공중합체, 이의 합성 방법, 및이로부터 제조된 하이드로겔 및 생체물질 |
US20040137059A1 (en) * | 2003-01-09 | 2004-07-15 | Thierry Nivaggioli | Biodegradable ocular implant |
US20040166088A1 (en) | 2003-01-15 | 2004-08-26 | Shalaby Shalaby W. | Polymeric precursors of non-absorbable, in situ-forming hydrogels and applications thereof |
US7144412B2 (en) | 2003-06-25 | 2006-12-05 | Wolf Medical Enterprises, Inc. | Gold suture and method of use in wound closure |
SI1635875T1 (sl) * | 2003-06-26 | 2009-04-30 | Psivida Inc | Sistem za dajanje zdravila, ki se gelira in situ |
WO2005000278A1 (en) * | 2003-06-26 | 2005-01-06 | Mediolanum Pharmaceuticals Ltd. | Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof |
EP1691852A2 (en) | 2003-11-10 | 2006-08-23 | Angiotech International AG | Medical implants and fibrosis-inducing agents |
AU2005210668A1 (en) | 2004-01-30 | 2005-08-18 | Angiotech International Ag | Compositions and methods for treating contracture |
US20050226814A1 (en) * | 2004-04-13 | 2005-10-13 | Bausch & Lomb Incorporated | Diagnostic method and kit for implantation of a sustained release drug-delivery implant with a steroid |
US7361168B2 (en) | 2004-04-21 | 2008-04-22 | Acclarent, Inc. | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders |
US7410480B2 (en) | 2004-04-21 | 2008-08-12 | Acclarent, Inc. | Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
US8119154B2 (en) * | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
CN1965101B (zh) * | 2004-06-07 | 2014-06-25 | 株式会社爱发科 | 磁控管溅射方法以及磁控管溅射装置 |
BRPI0516830A (pt) * | 2004-10-01 | 2008-09-23 | Ramscor Inc | composições de droga de liberação sustentada convenientemente implantáveis |
BRPI0516912A2 (pt) | 2004-11-24 | 2009-06-23 | Algorx Pharmaceuticals Inc | formulação a base do capsaicinoide em gel e usos da mesma |
US7611494B2 (en) | 2005-02-08 | 2009-11-03 | Confluent Surgical, Inc. | Spray for fluent materials |
US7610100B2 (en) | 2005-12-30 | 2009-10-27 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating osteoarthritis |
US7741273B2 (en) | 2006-04-13 | 2010-06-22 | Warsaw Orthopedic, Inc. | Drug depot implant designs |
US8802128B2 (en) * | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US20080091207A1 (en) | 2006-10-13 | 2008-04-17 | Csaba Truckai | Bone treatment systems and methods |
-
2009
- 2009-03-27 US US12/413,197 patent/US9125917B2/en active Active
- 2009-04-17 CN CN2009801006021A patent/CN101959520A/zh active Pending
- 2009-04-17 JP JP2010542440A patent/JP2011508791A/ja active Pending
- 2009-04-17 WO PCT/US2009/041043 patent/WO2009129511A2/en active Application Filing
- 2009-04-17 EP EP09733217A patent/EP2280712A4/en not_active Withdrawn
-
2015
- 2015-09-04 US US14/846,067 patent/US9763966B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010111178A4 (en) | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue | |
RU2010111357A (ru) | Составы, содержащие клонидин в разлагаемом полимере | |
RU2010111358A (ru) | Способы и композиции, содержащие клонидин, предназначенные для лечения послеоперационной боли | |
CN108136070A (zh) | 创伤后骨关节炎的预防性治疗 | |
JP2011508788A5 (ja) | ||
WO2009129509A4 (en) | Methods and compositions for treating post-operative pain comprising a local anesthetic | |
CN102458272B (zh) | 治疗与扁桃体切除术相关的疼痛的装置 | |
JP2011508791A5 (ja) | ||
RU2018100114A (ru) | Кортикостероиды для лечения суставной боли | |
WO2012075447A4 (en) | Compositions and methods for delivering clonidine and bupivacaine to a target tissue site | |
WO2011016881A4 (en) | An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation | |
WO2009129149A4 (en) | Drug depots having different release profiles for reducing, preventing or treating pain and inflammation | |
US20090028914A1 (en) | Medical devices incorporating collagen inhibitors | |
JP2014156496A5 (ja) | 生分解性眼内インプラント | |
Xue et al. | Local foreign-body reaction to commercial biodegradable implants: an in vivo animal study | |
MX2012010611A (es) | Dispositivos implantables heterogeneos para suministro de medicamento. | |
WO2009129147A4 (en) | Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation | |
JP2004210798A5 (ja) | ||
NZ595294A (en) | Intraocular sustained release drug delivery systems and methods for treating ocular conditions | |
Figueiredo | A five‐patient prospective pilot study of a polycaprolactone based dermal filler for hand rejuvenation | |
CN101091806A (zh) | 冠脉支架可降解药物缓释涂层 | |
WO2012075440A4 (en) | Compositions and methods for delivering clonidine to a target tissue site | |
WO2008024626A3 (en) | Bioresorbable stent with extended in vivo release of anti-restenotic agent | |
WO2009129510A4 (en) | Sulindac formulations in a biodegradable material | |
JPWO2016114216A1 (ja) | 生分解性ステント |